We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App

Novel Imaging Technique Could Transform Breast Cancer Detection

By MedImaging International staff writers
Posted on 12 Feb 2024
Print article
Image: The Radialis PET Imager (Photo courtesy of RSNA)
Image: The Radialis PET Imager (Photo courtesy of RSNA)

Mammography, while effective in the early detection of breast cancer, has reduced sensitivity in dense breast tissue due to the masking effect of dense fibroglandular tissue. This presents a challenge, as nearly half the screening population has dense breasts, often necessitating additional imaging, like MRI, after mammography. Now, a new study has found that low-dose positron emission mammography (PEM) not only offers high sensitivity in detecting breast cancer but also significantly lowers the likelihood of false positive results. This innovative molecular imaging technique, which operates at a radiation dose similar to traditional mammography, could provide a more reliable breast cancer screening option for a wider patient demographic.

The study by researchers at the University of Toronto (Ontario, Canada) involved 25 women, with a median age of 52, who had been recently diagnosed with breast cancer. They underwent low-dose PEM using the radiotracer fluorine 18-labeled fluorodeoxyglucose (18F-FDG). Two breast radiologists assessed the PEM images taken one and four hours after the 18F-FDG injection and matched their findings with laboratory results. The research revealed that PEM's performance paralleled that of MRI, identifying 24 out of 25 invasive cancers (96%) with a notably lower false positive rate of only 16%, compared to MRI’s 62%. PEM's sensitivity and reduced rate of false positives could potentially reduce downstream healthcare costs by eliminating the need for further unnecessary procedures, unlike MRI. Furthermore, PEM offers a patient-friendly experience by delivering a radiation dose similar to mammography without requiring uncomfortable breast compression.

The potential clinical applications of low-dose PEM extend to both screening and diagnostic scenarios. It could be instrumental in clarifying ambiguous mammogram results, evaluating chemotherapy responses, and determining the disease's extent in newly diagnosed breast cancer, including the involvement of the opposite breast. The University of Toronto team is currently exploring PEM's ability to decrease the high rates of false positives often associated with MRI scans. If PEM proves effective in reducing these rates, it could significantly alleviate the emotional distress and anxiety associated with false positives and may lead to fewer unnecessary biopsies and treatments. Further research is necessary to precisely define low-dose PEM’s role and effectiveness in clinical settings.

"The integration of these features—high sensitivity, lower false-positive rates, cost-efficiency, acceptable radiation levels without compression, and independence from breast density—positions this emerging imaging modality as a potential groundbreaking advancement in the early detection of breast cancer," said study lead author Vivianne Freitas, M.D., M.Sc., assistant professor at the University of Toronto. "As such, it holds the promise of transforming breast cancer diagnostics and screening in the near future, complementing or even improving current imaging methods, marking a significant step forward in breast cancer care."

Related Links:
University of Toronto

Gold Member
Solid State Kv/Dose Multi-Sensor
Gold Member
Radiation QA Tool
Accu-Gold 3
Dose Area Product Meter
DR Flat Panel Detector

Print article



view channel
Image: The VR visualization platform provides patients and surgeons with access to real-time 3D medical imaging (Photo courtesy of Avatar Medical)

VR Visualization Platform Creates 3D Patient Avatars from CT and MR Images in Real-Time

Surgeons and patients must currently rely on black and white medical images interpreted by radiologists. This limitation becomes more pronounced in complex surgeries, leading to issues such as patient... Read more


view channel
Image: Intravascular ultrasound provides a more accurate and specific picture of the coronary arteries (Photo courtesy of 123RF)

Intravascular Imaging Significantly Improves Outcomes in Cardiovascular Stenting Procedures

Individuals with coronary artery disease, which involves plaque accumulation in the arteries leading to symptoms like chest pain, shortness of breath, and heart attacks, often undergo a non-surgical procedure... Read more

Nuclear Medicine

view channel
Image: The PET imaging technique can noninvasively detect active inflammation before clinical symptoms arise (Photo courtesy of 123RF)

New PET Tracer Detects Inflammatory Arthritis Before Symptoms Appear

Rheumatoid arthritis, the most common form of inflammatory arthritis, affects 18 million people globally. It is a complex autoimmune disease marked by chronic inflammation, leading to cartilage and bone... Read more

General/Advanced Imaging

view channel
Image: Routine chest CT holds untapped potential for revealing patients at risk for cardiovascular disease (Photo courtesy of Johns Hopkins)

Routine Chest CT Exams Can Identify Patients at Risk for Cardiovascular Disease

Coronary artery disease (CAD) is the primary cause of death globally. Adults without symptoms but at risk can be screened using EKG-gated coronary artery calcium (CAC) CT scans, which are crucial in assessing... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more

Industry News

view channel
Image: The acquisition will expand IBA’s medical imaging quality assurance offering (Photo courtesy of Radcal)

IBA Acquires Radcal to Expand Medical Imaging Quality Assurance Offering

Ion Beam Applications S.A. (IBA, Louvain-La-Neuve, Belgium), the global leader in particle accelerator technology and a world-leading provider of dosimetry and quality assurance (QA) solutions, has entered... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.